1. Home
  2. HRB vs DNTH Comparison

HRB vs DNTH Comparison

Compare HRB & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$29.82

Market Cap

4.0B

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$87.17

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
DNTH
Founded
1955
2015
Country
United States
United States
Employees
N/A
92
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
HRB
DNTH
Price
$29.82
$87.17
Analyst Decision
Sell
Strong Buy
Analyst Count
2
13
Target Price
$41.00
$121.00
AVG Volume (30 Days)
1.6M
753.9K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
5.42%
N/A
EPS Growth
6.55
N/A
EPS
4.39
N/A
Revenue
$3,159,931,000.00
$2,036,000.00
Revenue This Year
$4.39
N/A
Revenue Next Year
$3.21
$29.48
P/E Ratio
$7.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.16
$16.77
52 Week High
$64.62
$96.50

Technical Indicators

Market Signals
Indicator
HRB
DNTH
Relative Strength Index (RSI) 40.99 54.75
Support Level $29.75 $33.94
Resistance Level $32.70 $88.45
Average True Range (ATR) 1.20 3.74
MACD -0.05 -1.19
Stochastic Oscillator 6.68 33.16

Price Performance

Historical Comparison
HRB
DNTH

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: